Singapore markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
60.60+1.07 (+1.80%)
At close: 04:00PM EDT
60.30 -0.30 (-0.50%)
Pre-market: 09:14AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts15151615
Avg. Estimate-1.16-1.14-4.69-4.2
Low estimate-1.38-1.42-5.43-5.97
High estimate-1.02-0.95-4.28-2.94
Year ago EPS-1.34-1.35-5.45-4.69
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts12121512
Avg. Estimate950k870k9.84M83M
Low estimateN/AN/A800k5M
High estimate2M1.32M53.36M225.9M
Year ago sales5.8M378k7.53M9.84M
Sales growth (year/est)-83.60%130.20%30.70%743.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.15-0.74-0.97-1.14
Actual EPS-1.34-1.35-1.38-1.33
Difference-0.19-0.61-0.41-0.19
Surprise %-16.50%-82.40%-42.30%-16.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.16-1.14-4.69-4.2
7 days ago-1.18-1.14-4.7-4.18
30 days ago-1.12-1.08-4.45-3.29
60 days ago-1.12-1.08-4.46-3.31
90 days ago-1.02-1.06-4.53-3.3
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days6541
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesCYTKIndustrySector(s)S&P 500
Current qtr.13.40%N/AN/AN/A
Next qtr.15.60%N/AN/AN/A
Current year13.90%N/AN/AN/A
Next year10.40%N/AN/AN/A
Next 5 years (per annum)15.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A